Locations:
Search
This cell surface protein could be an immune checkpoint inhibition target
Test can identify aggressive vs. indolent disease, reduce unneeded biopsies
What's driving tumor progression is the key, says Nima Sharifi, MD
Research program seeks new diagnostic and treatment options for kidney and urologic disease.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Correlation of systemic disease, urologic symptoms confirmed
Fostering collaboration between basic, translational scientists and clinicians
Could these be the culprits in the increasing incidence of kidney stones?
Why can male fertility be reduced even before treatment begins?
Using “opportunistic imaging” to identify significant comorbidities such as cardiovascular risk and bone health
Cleveland Clinic research team uses fMRI to assess real-time brain activity
Advertisement
Advertisement